In the last 12 months, insiders at Bionano Genomics, Inc. ($BNGO) filed 61 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Bionano Genomics, Inc. operates in the Laboratory analytical instruments industry (Industrial Applications and Services sector).
Most Active Insiders
- Holmlin R. Erik (PRESIDENT AND CEO) — 5 transactions totaling $3,959
- OLDAKOWSKI MARK (Chief Operating Officer) — 6 transactions totaling $2,406
- Chaubey Alka (Chief Medical Officer) — 5 transactions totaling $1,875
- OLDAKOWSKI MARK (CHIEF OPERATING OFFICER) — 5 transactions totaling $1,583
- Chaubey Alka (CHIEF MEDICAL OFFICER) — 5 transactions totaling $1,393
View all SEC Filings for Bionano Genomics, Inc. (BNGO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F | Common Stock | 18 | $1.10 | 644.0000 | 10,176,000 | 2.72% | 0.00% |
| Feb. 17, 2026 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | F | Common Stock | 20 | $1.10 | 895.0000 | 10,176,000 | 2.19% | 0.00% |
| Feb. 17, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | F | Common Stock | 51 | $1.10 | 1,657.0000 | 10,176,000 | 2.99% | 0.00% |
| Feb. 17, 2026 | Adamchak Mark | Principal Accounting Officer | F | Common Stock | 3 | $1.10 | 260.0000 | 10,176,000 | 1.14% | 0.00% |
| Feb. 17, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | F | Common Stock | 6 | $1.10 | 263.0000 | 10,176,000 | 2.23% | 0.00% |
| Feb. 2, 2026 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 27737 | $0.00 | 27,737.0000 | 10,176,000 | 9999.99% | 0.27% |
| Feb. 2, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 27737 | $0.00 | 27,737.0000 | 10,176,000 | 9999.99% | 0.27% |
| Feb. 2, 2026 | Adamchak Mark | Principal Accounting Officer | A | Stock Option (Right to Buy) | 10890 | $0.00 | 10,890.0000 | 10,176,000 | 9999.99% | 0.11% |
| Feb. 2, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 69484 | $0.00 | 69,484.0000 | 10,176,000 | 9999.99% | 0.68% |
| Feb. 2, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 26117 | $0.00 | 26,117.0000 | 10,176,000 | 9999.99% | 0.26% |
| Sept. 11, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F | Common Stock | 59 | $4.06 | 915.0000 | 3,007,000 | 6.06% | 0.00% |
| Sept. 11, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F | Common Stock | 59 | $4.06 | 915.0000 | 3,007,000 | 6.06% | 0.00% |
| Sept. 11, 2025 | Chaubey Alka | Chief Medical Officer | F | Common Stock | 51 | $4.06 | 662.0000 | 3,007,000 | 7.15% | 0.00% |
| June 11, 2025 | Rajkovic Aleksandar | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | Mamuszka Hannah | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | Vuori Kristiina MD | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | Luderer Albert | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | Linney Yvonne | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | BARKER DAVID L | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 11, 2025 | TWOMEY CHRISTOPHER J | Director | A | Stock Option (Right to Buy) | 2775 | $0.00 | 2,775.0000 | 3,007,000 | 9999.99% | 0.09% |
| June 3, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F | Common Stock | 27 | $3.69 | 974.0000 | 3,007,000 | 2.70% | 0.00% |
| June 3, 2025 | Adamchak Mark | Principal Accounting Officer | F | Common Stock | 7 | $3.69 | 263.0000 | 3,007,000 | 2.59% | 0.00% |
| June 3, 2025 | Chaubey Alka | Chief Medical Officer | F | Common Stock | 24 | $3.69 | 713.0000 | 3,007,000 | 3.26% | 0.00% |
| June 3, 2025 | Holmlin R. Erik | President and CEO | F | Common Stock | 75 | $3.69 | 1,716.0000 | 3,007,000 | 4.19% | 0.00% |
| June 3, 2025 | Dixon Jonathan V. | General Counsel | F | Common Stock | 25 | $3.69 | 269.0000 | 3,007,000 | 8.50% | 0.00% |
| March 14, 2025 | Chaubey Alka | Chief Medical Officer | A | Stock Option (Right to Buy) | 6966 | $0.00 | 6,966.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2025 | Dixon Jonathan V. | General Counsel | A | Stock Option (Right to Buy) | 6559 | $0.00 | 6,559.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2025 | Adamchak Mark | Principal Accounting Officer | A | Stock Option (Right to Buy) | 3029 | $0.00 | 3,029.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2025 | Holmlin R. Erik | President and CEO | F | Common Stock | 198 | $3.47 | 1,791.0000 | 0 | 9.95% | 0.00% |
| March 14, 2025 | Holmlin R. Erik | President and CEO | A | Stock Option (Right to Buy) | 17449 | $0.00 | 17,449.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | A | Stock Option (Right to Buy) | 6966 | $0.00 | 6,966.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2025 | Adamchak Mark | Principal Accounting Officer | F | Common Stock | 4 | $5.73 | 270.0000 | 0 | 1.46% | 0.00% |
| Feb. 15, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F | Common Stock | 20 | $5.73 | 1,001.0000 | 0 | 1.96% | 0.00% |
| Feb. 15, 2025 | Dixon Jonathan V. | General Counsel | F | Common Stock | 6 | $5.73 | 294.0000 | 0 | 2.00% | 0.00% |
| Feb. 15, 2025 | Holmlin R. Erik | President and CEO | F | Common Stock | 51 | $5.73 | 1,989.0000 | 0 | 2.50% | 0.00% |
| Feb. 15, 2025 | Chaubey Alka | Chief Medical Officer | F | Common Stock | 18 | $5.73 | 737.0000 | 0 | 2.38% | 0.00% |
| Oct. 1, 2024 | Adamchak Mark | Principal Accounting Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2024 | Chaubey Alka | Chief Medical Officer | F | Common Stock | 3075 | $0.48 | 45,323.0000 | 0 | 6.35% | 0.00% |
| Sept. 11, 2024 | OLDAKOWSKI MARK | Chief Operating Officer | F | Common Stock | 3568 | $0.48 | 61,283.0000 | 0 | 5.50% | 0.00% |
| June 18, 2024 | Rajkovic Aleksandar | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Luderer Albert | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Vuori Kristiina MD | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | BARKER DAVID L | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Wong Vincent Jung-Fai | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Linney Yvonne | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | TWOMEY CHRISTOPHER J | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Mamuszka Hannah | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | A | Common Stock | 16000 | $0.00 | 64,698.0000 | 0 | 32.86% | 0.00% |
| June 3, 2024 | Holmlin R. Erik | PRESIDENT AND CEO | A | Common Stock | 44000 | $0.00 | 122,315.0000 | 0 | 56.18% | 0.00% |
| June 3, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | A | Common Stock | 14500 | $0.00 | 18,025.0000 | 0 | 411.35% | 0.00% |
| June 3, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 68000 | $0.00 | 68,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | A | Common Stock | 16000 | $0.00 | 48,245.0000 | 0 | 49.62% | 0.00% |
| June 3, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Kama Gulsen | Chief Financial Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Kama Gulsen | Chief Financial Officer | A | Common Stock | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Holmlin R. Erik | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 204000 | $0.00 | 204,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Holmlin R. Erik | PRESIDENT AND CEO | F | Common Stock | 3073 | $1.27 | 78,165.0000 | 0 | 3.78% | 0.00% |
| Feb. 15, 2024 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | F | Common Stock | 1229 | $1.27 | 48,644.0000 | 0 | 2.46% | 0.00% |
| Feb. 15, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | F | Common Stock | 1081 | $1.27 | 31,487.0000 | 0 | 3.32% | 0.00% |
| Feb. 15, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | F | Common Stock | 402 | $1.27 | 3,525.0000 | 0 | 10.24% | 0.00% |